hypersensitivity vasculitis: Disorder characterized by a vasculitic syndrome associated with exposure to an antigen such as a drug, infectious agent, or other foreign or endogenous substance. Its pathophysiology includes immune complex deposition and a wide range of skin lesions. Hypersensitivity or allergy is present in some but not all cases.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
830 |
4. Check minimum number of eventsNone |
830 |
5. Include endpointsNone |
830 |
6. Filter based on genotype QC (FinnGen only) |
830 |
Control definitions (FinnGen only)
- Control exclude
- L12_OTHERSKINSUBCUTIS
Extra metadata
- Level in the ICD hierarchy
- 4
- First used in FinnGen datafreeze
- DF2
Similar endpoints
↥List of similar endpoints to
Other and unspecified vasculitis limited to skin
based on the number of shared cases.
Similar with more cases:
- Vasculitis limited to skin, not elsewhere classified
- Other disorders of skin and subcutaneous tissue
- Diseases of the skin and subcutaneous tissue
- Any event in hilmo or specialist outpatient
- Any prescribed medicine buy
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 5748 | 3379 | 2331 |
| Only index persons | 5105 | 3007 | 2098 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.08 | 0.10 | 0.07 |
| Only index persons | 0.10 | 0.11 | 0.08 |
| Median age at first event (years) | |||
| Whole population | 64.72 | 66.92 | 61.51 |
| Only index persons | 63.26 | 65.05 | 60.70 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 830 | 475 | 355 |
| Unadjusted period prevalence (%) | 0.16 | 0.16 | 0.16 |
| Median age at first event (years) | 61.52 | 60.40 | 63.01 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 754
- Matched controls
- 7538
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
L95.9
ICD-10 Finland
Vasculitis limited to skin, unspecified
13083.4
323.0
554
*
L95.8
ICD-10 Finland
Other vasculitis limited to skin
+∞
323.0
322
*
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
24.5
257.7
398
329
H02AB06
ATC
prednisolone; systemic
8.8
145.8
617
2554
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
83.8
139.2
154
23
D69.0
ICD-10 Finland
Allergic purpura
81.6
116.0
129
19
S97
ICPC
Chronic ulcer skin
17.2
99.6
164
120
L98.4
ICD-10 Finland
Chronic ulcer of skin, not elsewhere classified
99.9
88.4
96
11
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
13.7
77.8
140
123
J04BA02
ATC
dapsone; oral
207.8
73.6
75
*
L04AX01
ATC
azathioprine; systemic
14.1
71.1
126
106
A46
ICD-10 Finland
Erysipelas
5.4
65.1
226
551
L30.9
ICD-10 Finland
Dermatitis, unspecified
4.8
64.4
259
741
D07AC01
ATC
betamethasone; topical
3.8
64.2
394
1669
TQW80
NOMESCO Finland
Local dermatologic skincare
16.7
62.3
102
70
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
3.7
60.0
391
1709
SPAT1148
SPAT
Treatment of chronic ulcer or burn
5.1
59.3
217
554
J01FF01
ATC
clindamycin; systemic
3.8
56.1
315
1200
I83.0
ICD-10 Finland
Varicose veins of lower extremities with ulcer
18.0
55.5
88
55
L95.0
ICD-10 Finland
Livedoid vasculitis
+∞
52.7
50
*
QXB99
NOMESCO Finland
Other procedure to treat skin wound, unspecified location
25.6
48.5
68
29
E0000UV
ATC
NA
3.1
45.7
395
1993
XPX99
NOMESCO Finland
Other diagnostic examination of periferal vessel
7.2
45.4
117
188
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.9
43.2
429
2339
D07AD01
ATC
clobetasol; topical
4.0
43.1
199
616
C03CA01
ATC
furosemide; systemic
3.1
43.1
323
1459
QDB05
NOMESCO Finland
Revision of wound of skin of lower limb
15.0
39.1
66
48
QDG20
NOMESCO Finland
Operation for chronic ulcer or fistula of skin of lower limb
66.6
38.5
44
7
D07AB08
ATC
desonide; topical
4.6
38.3
147
378
N02AX02
ATC
tramadol; systemic, rectal
2.7
35.7
390
2159
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
4.2
35.3
148
412
A49.9
ICD-10 Finland
Bacterial infection, unspecified
4.2
33.7
140
386
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
3.6
33.4
169
553
J01DB01
ATC
cefalexin; oral
3.3
32.6
656
5061
I70.2
ICD-10 Finland
Atherosclerosis of arteries of extremities
4.8
32.3
115
271
ZZA00
NOMESCO Finland
Split skin graft
9.6
32.1
67
76
L04AX03
ATC
methotrexate; systemic (immunosuppressants)
4.1
31.0
133
376
L50.9
ICD-10 Finland
Urticaria, unspecified
7.9
29.4
69
95
A02BC02
ATC
pantoprazole; systemic
2.5
29.3
543
3820
L04AA06
ATC
mycophenolic acid; systemic
16.1
29.0
47
31
H02AB07
ATC
prednisone; oral
3.3
28.3
160
565
S18
ICPC
Laceration/cut
2.4
27.9
375
2216
R21
ICD-10 Finland
Rash and other nonspecific skin eruption
6.3
26.4
73
127
E000001
ATC
NA
2.7
26.0
207
912
D07AC13
ATC
mometasone; topical
2.5
24.8
258
1317
P01BA02
ATC
hydroxychloroquine; oral
3.8
24.4
110
321
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.4
24.2
271
1432
J01MA02
ATC
ciprofloxacin; systemic
2.3
24.2
343
2031
M31.9
ICD-10 Finland
Necrotizing vasculopathy, unspecified
58.0
24.2
28
5
L98.9
ICD-10 Finland
Disorder of skin and subcutaneous tissue, unspecified
39.0
24.1
30
8
N08.2*D69.0
ICD-10 Finland
Glomerular disorders in Henoch(-Schönlein) purpura
+∞
24.1
23
*
XQ848
NOMESCO Finland
Dermatological photography
8.8
24.0
52
63
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
4.2
23.5
94
246
M04AA01
ATC
allopurinol; systemic
3.1
23.5
145
539
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.5
23.5
228
1113
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
3.9
23.4
104
300
I87.2
ICD-10 Finland
Venous insufficiency (chronic)(peripheral)
3.4
22.9
122
408
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
3.7
22.8
106
317
N08.2*D89.80
ICD-10 Finland
Immunoglobulin A (IgA) nephropathy
41.5
22.8
28
7
D07BB04
ATC
hydrocortisone butyrate and antiseptics; topical
3.2
22.3
132
474
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
3.2
22.1
129
460
I50.9
ICD-10 Finland
Heart failure, unspecified
2.9
22.0
150
591
J01MA12
ATC
levofloxacin; systemic
2.6
21.8
181
807
I83.1
ICD-10 Finland
Varicose veins of lower extremities with inflammation
8.8
20.9
45
54
I83.2
ICD-10 Finland
Varicose veins of lower extremities with both ulcer and inflammation
79.1
20.8
23
*
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
2.9
20.8
138
536
N02AA05
ATC
oxycodone; systemic
2.7
20.5
154
645
L04AA01
ATC
[U] ciclosporin; systemic
13.5
20.4
35
27
L89
ICD-10 Finland
Decubitus ulcer and pressure area
49.5
20.3
24
5
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
4.0
20.2
84
228
C03DA01
ATC
spironolactone; oral
3.0
20.1
125
463
R50.9
ICD-10 Finland
Fever, unspecified
2.8
19.2
135
542
R60.0
ICD-10 Finland
Localized oedema
2.9
19.1
125
479
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
3.4
19.1
97
311
S76
ICPC
Skin infection other
4.8
18.9
65
146
NHQ40
NOMESCO Finland
Amputation of toe
13.9
18.9
32
24
PG1DE
NOMESCO Finland
Other extensive ultrasound examination of artery
4.9
18.8
63
138
ZXE00
NOMESCO Finland
One hour or less
2.0
18.7
332
2094
M30.0
ICD-10 Finland
Polyarteritis nodosa
102.6
18.6
20
*
TQW11
NOMESCO Finland
Vacuum treatment of wound
9.5
18.6
38
42
J01CF05
ATC
flucloxacillin; systemic
6.1
18.5
51
89
KA3AT
NOMESCO Finland
Biopsy of kidney with ultrasound guidance
12.3
18.4
33
28
L50.8
ICD-10 Finland
Other urticaria
9.7
18.3
37
40
A10AB05
ATC
insulin aspart; parenteral (insulins and analog. for injection, fast-acting)
3.6
18.2
85
255
H02AB09
ATC
hydrocortisone; systemic
7.5
17.8
42
59
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
2.5
17.7
152
682
N03AX16
ATC
pregabalin; oral
2.3
17.5
200
1035
SPAT1149
SPAT
Suture or treatment of traumatic wound
2.7
17.3
131
547
B01AA03
ATC
warfarin; systemic
2.3
17.2
190
968
E11.7
ICD-10 Finland
Type 2 diabetes mellitus, with multiple complications
4.4
17.1
64
157
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
2.5
17.1
151
689
D69.2
ICD-10 Finland
Other nonthrombocytopenic purpura
22.5
16.9
24
11
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.5
16.7
149
682
E000003
ATC
NA
4.7
16.6
57
128
R06.0
ICD-10 Finland
Dyspnoea
2.1
16.5
219
1210
A41.9
ICD-10 Finland
Sepsis, unspecified
5.3
16.2
50
100
L52
ICD-10 Finland
Erythema nodosum
17.2
16.2
25
15
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
4.0
15.9
65
174
L81.7
ICD-10 Finland
Pigmented purpuric dermatosis
61.4
15.8
18
*
L88
ICD-10 Finland
Pyoderma gangrenosum
+∞
15.7
15
*
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
3.7
15.6
71
208
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
2.2
15.5
196
1057
C07AB07
ATC
bisoprolol; oral
1.9
15.5
379
2636
M13.9
ICD-10 Finland
Arthritis, unspecified
3.3
15.4
82
272
ZXD05
NOMESCO Finland
Urgent procedure
2.0
15.4
253
1520
NH1AA
NOMESCO Finland
Ankle X-ray examination without contrast
3.6
15.3
71
212
D07AB02
ATC
hydrocortisone butyrate; topical
2.0
15.2
227
1310
PD4CG
NOMESCO Finland
Extensive MRI examination of abdominal aortta and vasculature of lower extremities with high intensity magnet
15.4
15.0
24
16
WZC30
NOMESCO Finland
Teaching
2.5
14.9
125
549
N17.9
ICD-10 Finland
Acute renal failure, unspecified
4.8
14.9
50
110
I50.0
ICD-10 Finland
Congestive heart failure
3.1
14.9
84
290
I48
ICD-10 Finland
Atrial fibrillation and flutter
2.1
14.8
202
1121
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
3.1
14.7
83
286
UJF32
NOMESCO Finland
Coloscopy
2.0
14.6
213
1217
ZXE10
NOMESCO Finland
More than one and less than three hours
1.9
14.6
293
1889
M35.9
ICD-10 Finland
Systemic involvement of connective tissue, unspecified
10.3
14.6
28
28
L01BA01
ATC
methotrexate; systemic (folic acid analog.)
4.2
14.2
54
135
A10AC01
ATC
insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)
3.2
14.2
79
268
SPAT1144
SPAT
Treatment of reopened or infected surgical wound
3.1
14.2
80
276
A02BC01
ATC
omeprazole; systemic
2.0
14.0
240
1452
M31.8
ICD-10 Finland
Other specified necrotizing vasculopathies
54.4
13.9
16
*
M05BA04
ATC
alendronic acid; oral
2.8
13.6
91
351
M79.6
ICD-10 Finland
Pain in limb
1.9
13.6
279
1801
A41.0
ICD-10 Finland
Sepsis due to Staphylococcus aureus
8.6
13.6
29
35
205
Kela drug reimbursment
Chronic hypertension
1.9
13.6
237
1441
SPAT1211
SPAT
Application of soft bandage
2.8
13.6
94
370
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
3.8
13.5
58
162
D02AX
ATC
Other emollients and protectives
4.8
13.5
45
99
D09AB01
ATC
zinc bandage without supplements; topical
6.1
13.5
36
61
D69.9
ICD-10 Finland
Haemorrhagic condition, unspecified
21.6
13.4
19
9
XF600
NOMESCO Finland
Bloodpressure measurement
3.4
13.4
66
207
E11.5
ICD-10 Finland
Type 2 diabetes mellitus, with peripheral circulatory complications
9.9
13.3
26
27
B01AB05
ATC
enoxaparin; parenteral
1.9
13.3
248
1547
SPAT1156
SPAT
Guidance concerning treatment of rash and skin
2.4
13.1
124
580
TPH04
NOMESCO Finland
Cathetrisation of vein
2.1
13.0
176
970
S81.8
ICD-10 Finland
Open wound of other parts of lower leg
5.2
12.9
40
81
N03AX12
ATC
gabapentin; oral
2.3
12.9
136
668
S29
ICPC
Skin symptom/complaint other
2.2
12.8
154
803
R70.0
ICD-10 Finland
Elevated erythrocyte sedimentation rate
6.1
12.7
34
58
PF1AT
NOMESCO Finland
Intravascular dilatation of arteries of knee, lower leg and ankle (PTA)
15.8
12.7
20
13
SPAT1151
SPAT
Treatment of major wounds
8.4
12.6
27
33
R06AE09
ATC
levocetirizine; oral
2.3
12.6
124
592
L01AA01
ATC
cyclophosphamide; systemic
24.8
12.5
17
7
WX213
NOMESCO Finland
Lower leg blockade
13.5
12.5
21
16
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
3.1
12.5
71
247
L08.9
ICD-10 Finland
Local infection of skin and subcutaneous tissue, unspecified
4.7
12.2
41
91
I10
ICD-10 Finland
Essential (primary) hypertension
1.7
12.1
439
3357
D03BA02
ATC
collagenase; topical
27.2
12.1
16
6
I50
ICD-10 Finland
Heart failure
4.7
12.0
40
88
L04AD01
ATC
ciclosporin; systemic
6.6
12.0
30
47
Z3231
NOMESCO Finland
Registered nurse
1.9
11.9
226
1406
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
3.2
11.9
62
203
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
3.2
11.9
63
209
KA1AE
NOMESCO Finland
Kidney ultrasound examination
5.1
11.6
36
74
Z2221
NOMESCO Finland
Medical doctor
1.9
11.5
218
1351
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
2.7
11.5
83
336
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
2.8
11.5
78
303
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.7
11.4
368
2698
J01DA01
ATC
[U] cefalexin; systemic
1.7
11.4
459
3588
L02.4
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of limb
4.4
11.4
41
98
J45.9
ICD-10 Finland
Asthma, unspecified
2.1
11.3
146
784
G47.3
ICD-10 Finland
Sleep apnoea
2.0
11.3
165
931
D69.6
ICD-10 Finland
Thrombocytopenia, unspecified
6.6
11.2
28
44
QD9S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in lower extremities, unspecified
25.4
11.2
15
6
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.7
11.2
341
2454
A28
ICPC
Limited function/disability NOS
2.2
11.0
126
643
UGC12
NOMESCO Finland
Flexible bronchoscopy
2.8
10.9
72
276
D64.9
ICD-10 Finland
Anaemia, unspecified
2.4
10.9
98
445
L08.8
ICD-10 Finland
Other specified local infections of skin and subcutaneous tissue
5.5
10.8
31
58
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
2.8
10.8
70
263
S81.9
ICD-10 Finland
Open wound of lower leg, part unspecified
10.8
10.8
20
19
QDE35
NOMESCO Finland
Repair of skin defect in lower limb after surgery or injury
28.5
10.8
14
5
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
2.0
10.6
144
788
N18.8
ICD-10 Finland
Other chronic renal failure
4.2
10.6
39
96
JN3BD
NOMESCO Finland
Extensive abdominal CT
2.4
10.6
91
405
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
4.1
10.6
40
101
QDB10
SPAT
NA
19.1
10.3
15
8
J01FA06
ATC
roxithromycin; oral
1.7
10.3
293
2052
N02BE01
ATC
paracetamol; systemic, rectal
1.9
10.3
637
5581
ZY010
NOMESCO Finland
Hospital outpatient
3.5
10.3
47
140
A10BA02
ATC
metformin; oral
1.8
10.3
211
1338
103
Kela drug reimbursment
Diabetes, insulin-treated
1.8
10.3
205
1287
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
3.6
10.2
46
135
R03BB04
ATC
tiotropium bromide; inhalant
2.4
10.1
86
382
R23.3
ICD-10 Finland
Spontaneous ecchymoses
5.9
10.0
27
47
E000006
ATC
NA
2.8
10.0
66
252
A10AE05
ATC
insulin detemir; parenteral
3.1
10.0
54
182
D69
ICD-10 Finland
Purpura and other haemorrhagic conditions
40.6
10.0
12
*
D02AE01
ATC
carbamide; topical
2.8
9.9
62
230
SPAT1260
SPAT
Consultation of another employee
1.9
9.9
150
855
D07BC01
ATC
betamethasone and antiseptics; topical
2.2
9.9
103
500
S91.0
ICD-10 Finland
Open wound of ankle
12.4
9.9
17
14
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
2.7
9.9
69
274
I50.1
ICD-10 Finland
Left ventricular failure
3.3
9.8
49
156
L03.9
ICD-10 Finland
Cellulitis, unspecified
5.1
9.8
30
61
G62.9
ICD-10 Finland
Polyneuropathy, unspecified
3.6
9.8
43
124
N08.2
ICD-10 Finland
Glomerular disorders in blood diseases and disorders involving the immune mechanism
55.7
9.7
11
*
ZXD10
NOMESCO Finland
Scheduled procedure
1.7
9.7
285
2007
Z2446
NOMESCO Finland
Social worker
2.7
9.7
65
253
WX892
NOMESCO Finland
Monitored bed care
2.6
9.6
68
272
L84
ICD-10 Finland
Corns and callosities
4.9
9.6
30
63
WX408
NOMESCO Finland
General anesthesy, balanced
1.8
9.5
205
1314
NG4AA
NOMESCO Finland
Lower leg X-ray examination
4.4
9.5
33
77
L30.3
ICD-10 Finland
Infective dermatitis
3.9
9.4
38
102
M30.8
ICD-10 Finland
Other conditions related to polyarteritis nodosa
101.2
9.4
10
*
A07EC01
ATC
sulfasalazine; oral, rectal
2.5
9.4
73
308
J01MA14
ATC
moxifloxacin; systemic
2.5
9.4
76
329
S91.3
ICD-10 Finland
Open wound of other parts of foot
5.3
9.3
27
52
C02AC05
ATC
moxonidine; oral
3.2
9.2
48
159
TGC00
NOMESCO Finland
Bronchial lavation
4.5
9.1
31
71
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.6
9.1
291
2088
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
2.3
9.1
82
375
QDA10
NOMESCO Finland
Incision of skin of lower limb
15.8
9.1
14
9
R03DC03
ATC
montelukast; oral
2.0
9.0
125
686
XF400
NOMESCO Finland
ECG with 12 standard connections
1.9
9.0
136
773
R4110
NOMESCO Finland
Physiotherapy
1.7
9.0
200
1291
SPAT1262
SPAT
Handing over of treatment supplies
1.9
9.0
146
851
L03.1
ICD-10 Finland
Cellulitis of other parts of limb
4.6
8.9
30
68
R53
ICD-10 Finland
Malaise and fatigue
1.8
8.9
160
966
A10AE04
ATC
insulin glargine; parenteral
2.3
8.9
80
364
R06AE07
ATC
cetirizine; oral
1.6
8.8
306
2242
TPH07
NOMESCO Finland
Cathetrisation of artery
2.2
8.7
87
416
B01AB04
ATC
dalteparin; parenteral
2.9
8.7
51
182
NFQ20
NOMESCO Finland
Amputation of femur
14.2
8.7
14
10
L14
ICPC
Leg/thigh symptom/complaint
2.5
8.7
68
287
L27.0
ICD-10 Finland
Generalized skin eruption due to drugs and medicaments
7.8
8.7
19
25
SPAT1263
SPAT
Sampling
1.6
8.7
311
2290
NHQ30
NOMESCO Finland
Amputation of foot, transmetatarsal
16.5
8.6
13
8
M32.9
ICD-10 Finland
Systemic lupus erythematosus, unspecified
10.2
8.6
16
16
L30.0
ICD-10 Finland
Nummular dermatitis
4.1
8.5
32
81
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
2.0
8.5
107
566
C08CA13
ATC
lercanidipine; oral
2.0
8.5
108
571
X59
ICD-10 Finland
Exposure to unspecified factor
1.9
8.5
137
797
N19
ICD-10 Finland
Unspecified kidney failure
3.7
8.4
35
97
E11.8
ICD-10 Finland
Type 2 diabetes mellitus, with unspecified complications
2.2
8.4
85
409
ZX112
NOMESCO Finland
Subcutaneous
4.6
8.4
28
63
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
3.9
8.4
33
87
M30.1
ICD-10 Finland
Polyarteritis with lung involvement [Churg-Strauss]
91.0
8.4
9
*
XW000
NOMESCO Finland
Bone marrow biopsy
3.2
8.4
42
135
PD4DE
NOMESCO Finland
Lower extremity artery ultrasound examination with Doppler method
6.8
8.4
20
30
L94.2
ICD-10 Finland
Calcinosis cutis
+∞
8.3
8
*
L59.9
ICD-10 Finland
Disorder of skin and subcutaneous tissue related to radiation, unspecified
+∞
8.3
8
*
L95.1
ICD-10 Finland
Erythema elevatum diutinum
+∞
8.3
8
*
M10.9
ICD-10 Finland
Gout, unspecified
2.7
8.3
57
225
ZX120
NOMESCO Finland
Intravenous
2.2
8.3
81
383
Z71.8
ICD-10 Finland
Other specified counselling
1.8
8.2
173
1092
XQ902
NOMESCO Finland
Other photography
14.7
8.2
13
9
L17
ICPC
Foot/toe symptom/complaint
1.7
8.2
190
1240
C01AA05
ATC
digoxin; systemic
2.4
8.1
71
319
SPAT1153
SPAT
Removal of sutures
1.6
8.1
236
1637
E11
ICD-10 Finland
Type 2 diabetes mellitus
1.9
8.1
122
689
N03.9
ICD-10 Finland
Chronic nephritic syndrome, unspecified
17.4
8.1
12
7
M35.0
ICD-10 Finland
Sicca syndrome [Sjögren]
4.4
8.1
28
66
S19
ICPC
Skin injury other
3.4
8.0
37
112
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
3.5
8.0
36
107
PD4AC
NOMESCO Finland
Arterigography of lower extremity with X-ray
7.3
8.0
18
25
A02BA02
ATC
ranitidine; systemic
1.8
8.0
154
949
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
2.2
8.0
84
413
E000002
ATC
NA
2.1
7.9
88
442
ZY020
NOMESCO Finland
Telephone, letter or other consultation without direct patient contact
2.5
7.9
60
249
I80.3
ICD-10 Finland
Phlebitis and thrombophlebitis of lower extremities, unspecified
3.4
7.9
37
114
ZXE20
NOMESCO Finland
More than three and less than five hours
2.0
7.9
111
611
B01AB10
ATC
tinzaparin; parenteral
2.4
7.9
66
290
Z01.5
ICD-10 Finland
Diagnostic skin and sensitization tests
2.3
7.8
73
337
C08DB01
ATC
diltiazem; oral
2.7
7.8
53
208
A12BA01
ATC
potassium chloride; oral
2.8
7.7
49
184
Z3226
NOMESCO Finland
Physiotherapist
1.8
7.6
145
887
A04.7
ICD-10 Finland
Enterocolitis due to Clostridium difficile
4.0
7.6
29
75
C08CA02
ATC
felodipine; oral
2.2
7.6
81
399
B35.3
ICD-10 Finland
Tinea pedis
3.1
7.5
40
135
H02AB04
ATC
methylprednisolone; systemic
1.9
7.5
109
609
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
1.8
7.5
136
819
J45.0
ICD-10 Finland
Predominantly allergic asthma
2.4
7.5
64
285
215
Kela drug reimbursment
Diabetes, non-insulin-treated
1.7
7.5
175
1140
D07BA04
ATC
hydrocortisone and antiseptics; topical
2.1
7.4
80
395
A06AD11
ATC
lactulose; oral
1.9
7.3
116
668
S99
ICPC
Skin disease other
4.6
7.3
24
54
QDA99
NOMESCO Finland
Other local destruction of skin of lower limb
11.0
7.3
13
12
M36.4*D69.0
ICD-10 Finland
Arthropathy in Henoch(-Schönlein) purpura
+∞
7.3
7
*
L50.3
ICD-10 Finland
Dermatographic urticaria
6.3
7.3
18
29
I73.0
ICD-10 Finland
Raynaud syndrome
6.3
7.3
18
29
Z01.8
ICD-10 Finland
Other specified special examinations
1.7
7.3
151
949
-56
ICPC
Dressing/pressure/compress/tamponade
5.5
7.3
20
37
NGQ20
NOMESCO Finland
Amputation of lower leg
15.9
7.2
11
7
M79.3
ICD-10 Finland
Panniculitis, unspecified
15.9
7.2
11
7
XQ800
NOMESCO Finland
Prick test
2.4
7.2
57
245
M05.2
ICD-10 Finland
Rheumatoid vasculitis
30.3
7.2
9
*
285
Kela drug reimbursment
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)
2.9
7.1
41
145
L40.0
ICD-10 Finland
Psoriasis vulgaris
3.1
7.1
37
124
NH3BA
NOMESCO Finland
Foot and toes extensive X-ray examination
3.5
7.1
31
91
208
Kela drug reimbursment
Ulcerative colitis and Crohn's disease
3.0
7.1
38
130
T90
ICPC
Diabetes non-insulin dependent
1.7
7.0
168
1103
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
1.7
6.9
165
1081
ZX108
NOMESCO Finland
Inhalation
8.4
6.8
14
17
160
Kela drug reimbursment
exenatide
4.6
6.8
22
49
D72.1
ICD-10 Finland
Eosinophilia
11.1
6.8
12
11
M31.0
ICD-10 Finland
Hypersensitivity angiitis
40.4
6.8
8
*
RJ411
NOMESCO Finland
NA
16.9
6.8
10
6
M31.3
ICD-10 Finland
Wegener granulomatosis
16.9
6.8
10
6
PF1BT
NOMESCO Finland
Extensive PTA of arteries of knee, lower leg and ankle
16.9
6.8
10
6
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.6
6.7
240
1739
A08
ICPC
Swelling
2.8
6.7
41
153
H26.3
ICD-10 Finland
Drug-induced cataract
22.7
6.7
9
*
R10.1
ICD-10 Finland
Pain localized to upper abdomen
1.8
6.7
114
672
R06AX27
ATC
desloratadine; oral
1.6
6.7
183
1244
M06.9
ICD-10 Finland
Rheumatoid arthritis, unspecified
3.6
6.7
28
80
PD4BC
NOMESCO Finland
Extensive arterigography of lower extremity with X-ray
5.6
6.6
18
33
SPAT1225
SPAT
Implementation of podiatry rehabilitation plan
3.8
6.6
26
70
M10.0
ICD-10 Finland
Idiopathic gout
3.2
6.6
32
102
A10BH01
ATC
sitagliptin; oral
2.1
6.6
72
358
C09AA05
ATC
ramipril; oral
1.6
6.6
182
1235
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
1.6
6.6
232
1676
R07.4
ICD-10 Finland
Chest pain, unspecified
1.6
6.6
197
1368
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
2.6
6.5
46
185
XQ858
NOMESCO Finland
Oxygen partial pressure measurement
10.1
6.5
12
12
R03AC02
ATC
salbutamol; inhalant
1.5
6.5
365
2920
L50.0
ICD-10 Finland
Allergic urticaria
3.9
6.5
25
66
A10BB12
ATC
glimepiride; oral
2.3
6.5
60
277
346
Kela drug reimbursment
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)
3.0
6.5
37
129
J44.9
ICD-10 Finland
Chronic obstructive pulmonary disease, unspecified
2.8
6.5
39
144
C09AA02
ATC
enalapril; systemic
1.7
6.5
144
922
L93.0
ICD-10 Finland
Discoid lupus erythematosus
70.4
6.4
7
*
D89.1
ICD-10 Finland
Cryoglobulinaemia
70.4
6.4
7
*
TQW99
NOMESCO Finland
Other minor procedure on skin
2.8
6.4
39
145
J44.8
ICD-10 Finland
Other specified chronic obstructive pulmonary disease
2.1
6.4
71
357
M86.9
ICD-10 Finland
Osteomyelitis, unspecified
14.5
6.4
10
7
T79.3
ICD-10 Finland
Post-traumatic wound infection, not elsewhere classified
6.6
6.4
15
23
E66.2
ICD-10 Finland
Extreme obesity with alveolar hypoventilation
8.2
6.3
13
16
WVA40
NOMESCO Finland
Initiation and monitoring of intravenous hydration
9.4
6.3
12
13
J01AA02
ATC
doxycycline; systemic
1.5
6.3
550
4820
A18.4
ICD-10 Finland
Tuberculosis of skin and subcutaneous tissue
+∞
6.3
6
*
M30
ICD-10 Finland
Polyarteritis nodosa and related conditions
+∞
6.3
6
*
L98.1
ICD-10 Finland
Factitial dermatitis
+∞
6.3
6
*
WX212
NOMESCO Finland
Femoral plexus blockade
4.2
6.2
22
54
L28
ICPC
Limited function/disability (L)
1.8
6.2
117
712
Z46.8
ICD-10 Finland
Fitting and adjustment of other specified devices
3.7
6.2
25
69
D07AA02
ATC
hydrocortisone; topical
1.9
6.2
98
561
E66.8
ICD-10 Finland
Other obesity
2.7
6.2
40
153
AA1AD
NOMESCO Finland
CT of head and brain
1.6
6.2
170
1153
A12AA04
ATC
calcium carbonate; oral
5.8
6.2
16
28
Z01.0
ICD-10 Finland
Examination of eyes and vision
1.8
6.1
116
706
R4180
NOMESCO Finland
Podiatric therapy
7.8
6.1
13
17
DHA10
NOMESCO Finland
Biopsy of cavity of nose
7.8
6.1
13
17
R5110
SPAT
NA
3.7
6.1
25
70
C08CA05
ATC
nifedipine; systemic
2.4
6.1
52
230
P01AB01
ATC
metronidazole; oral, rectal
1.5
6.1
265
1998
K52.9
ICD-10 Finland
Noninfective gastroenteritis and colitis, unspecified
3.1
6.1
31
103
QDA25
NOMESCO Finland
Destruction of lesion of skin of lower limb
12.6
6.1
10
8
UKC02
NOMESCO Finland
Cystoscopy
1.7
6.0
117
719
QDB99
NOMESCO Finland
Other procedure for wound of skin of lower limb
10.1
6.0
11
11
M80.9
ICD-10 Finland
Unspecified osteoporosis with pathological fracture
4.2
6.0
21
51
N08.39*E11.2
ICD-10 Finland
Non-insulin-dependent diabetes mellitus - Diabetic nephropathy
5.2
6.0
17
33
N02AJ06
ATC
codeine and paracetamol; systemic
1.5
6.0
253
1897
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
283
215
19.46
315.73
2.0
1.5
titre
98.6
210.0
—
14
10
(3009445) Proteinase 3 Ab [Units/volume] in Serum
339
275
20.15
307.65
1.9
1.5
u/ml
34.1
8.8
—
9
8
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
291
190
23.04
307.65
1.8
1.5
g/l
1.2
1.2
0.91
279
183
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
291
184
23.81
307.65
1.8
1.5
g/l
0.2
0.2
0.19
279
177
(40768443) Skin Pathology biopsy report
284
250
16.75
290.16
1.5
1.2
—
—
—
0
0
(3015171) Extractable nuclear Ab [Units/volume] in Serum
247
213
16.09
253.63
1.4
1.2
u/ml
1.5
2.3
0.17
18
12
(3037522) Nuclear Ab [Titer] in Serum
400
822
8.46
208.07
1.7
1.3
titre
495.8
488.2
0.02
106
176
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
152
113
16.24
167.30
1.6
1.3
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
152
195
9.32
114.72
2.6
1.9
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
233
557
5.43
95.42
2.3
2.9
g/l
67.1
66.3
0.76
217
502
(3004588) Protein electrophoresis panel - Serum or Plasma
212
467
5.75
95.19
2.2
2.5
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
635
3302
4.93
91.17
12.3
5.6
e9/l
0.6
0.6
3.44
585
2846
(3006315) Basophils [#/volume] in Blood
636
3316
4.93
90.85
12.3
5.6
e9/l
0.0
0.0
0.62
587
2869
(3007853) Bacteria identified in Skin by Aerobe culture
264
730
4.84
90.32
3.5
1.5
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
638
3387
4.82
87.51
12.3
5.7
e9/l
1.8
1.9
0.59
588
2967
(3013115) Eosinophils [#/volume] in Blood
640
3441
4.76
85.32
12.7
5.9
e9/l
0.2
0.2
0.25
592
3012
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
118
159
8.49
84.76
1.3
1.2
u/ml
4.4
14.2
0.63
16
23
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
116
158
8.37
82.52
1.3
1.2
u/ml
12.0
2.9
—
9
15
(3022096) Basophils/100 leukocytes in Blood
588
3047
4.19
80.73
12.7
5.8
%
0.6
0.7
2.65
573
2825
(42870588) Differential panel, method unspecified - Blood
489
2254
3.85
79.68
10.6
5.6
—
—
—
0
0
(3006504) Eosinophils/100 leukocytes in Blood
596
3137
4.19
79.49
12.7
5.8
%
2.6
2.9
2.07
580
2904
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
103
130
8.90
77.89
1.3
1.2
u/ml
1.3
11.8
—
5
8
(3019069) Monocytes/100 leukocytes in Blood
595
3157
4.12
77.72
12.9
6.1
%
8.4
8.7
2.16
578
2943
(3018010) Neutrophils/100 leukocytes in Blood
595
3179
4.08
76.38
12.0
5.7
%
61.3
57.6
11.56
576
2964
(3002030) Lymphocytes/100 leukocytes in Blood
600
3226
4.10
76.25
12.8
5.9
%
24.3
27.4
10.08
582
2990
(3036481) Cortisol [Moles/volume] in Serum or Plasma
217
620
4.38
69.48
3.0
2.0
nmol/l
318.3
376.8
4.06
207
571
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
81
87
10.21
69.13
1.3
1.2
u/ml
2.0
4.9
0.59
32
30
(3013650) Neutrophils [#/volume] in Blood by Automated count
654
3883
4.23
68.23
15.3
8.9
e9/l
4.8
4.1
9.20
606
3398
(3005719) IgG [Mass/volume] in Serum or Plasma
188
492
4.65
67.29
4.3
2.7
g/l
11.1
10.7
0.44
176
447
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
64
52
13.25
65.67
1.3
1.2
titre
134.0
98.8
—
15
8
(3017143) Hepatitis C virus Ab [Presence] in Serum
219
667
4.10
63.83
1.6
1.5
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
162
393
4.88
63.48
2.1
1.6
g/l
1.3
1.3
0.16
147
362
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
90
124
8.02
63.01
1.4
1.2
u/ml
39.7
43.6
—
11
7
(3021440) Promyelocytes/100 leukocytes in Blood
191
531
4.37
62.94
6.6
4.2
%
0.1
0.1
0.15
68
152
(3017181) Myelocytes/100 leukocytes in Blood
194
563
4.19
60.15
6.6
4.1
%
0.9
0.8
0.30
71
167
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
126
262
5.49
58.89
2.4
2.5
g/l
4.3
3.6
3.72
99
192
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
126
263
5.47
58.63
2.4
2.5
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
126
263
5.47
58.63
2.4
2.5
g/l
7.4
7.4
0.11
100
199
(3000850) Epithelial cells [#/volume] in Urine
344
1475
3.28
58.55
4.3
2.5
e6/l
5.5
5.9
0.15
319
1311
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
479
2487
3.19
58.55
5.6
3.1
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
338
1444
3.26
57.73
9.5
4.3
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
177
501
4.22
56.53
6.9
4.2
%
0.1
0.1
0.09
58
130
(3002179) Metamyelocytes/100 leukocytes in Blood
177
506
4.18
55.73
6.2
3.9
%
0.5
0.4
0.19
55
121
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
112
224
5.62
54.50
2.8
2.8
g/l
0.6
0.9
0.42
102
198
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
117
244
5.42
54.36
2.5
2.6
g/l
3.2
3.2
0.09
100
196
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
106
202
5.87
54.32
2.6
2.7
g/l
0.0
0.0
0.11
101
187
(3021589) Normoblasts [#/volume] in Blood
525
2973
3.08
53.21
21.0
9.3
e9/l
0.0
0.0
0.07
466
2438
(3042936) Bacteria identified in Isolate by Culture
256
968
3.38
52.85
3.1
1.9
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
116
246
5.32
52.84
2.5
2.6
g/l
10.8
10.3
0.48
109
213
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
211
707
3.66
52.65
6.3
3.4
—
—
—
0
0
(3026782) Osmolality of Urine
320
1387
3.13
52.40
4.6
2.8
mosm/kgh2o
512.2
550.4
2.98
297
1198
(3030467) Casts [#/volume] in Urine by Automated count
393
1918
2.99
51.93
5.2
3.1
e6/l
0.3
0.5
2.86
345
1456
(3002582) Erythrocytes [#/volume] in Urine
416
2100
2.97
51.57
5.4
3.2
e6/l
85.4
94.9
0.06
370
1638
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
33
11
31.20
50.01
1.2
1.1
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
379
1873
2.88
48.03
7.7
4.1
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
215
772
3.41
47.73
3.4
2.5
%
2.0
1.8
1.60
192
682
(3023520) Reticulocytes [#/volume] in Blood
179
576
3.69
47.05
2.7
2.4
e9/l
78.0
70.6
1.37
132
451
(36304419) Bacteria [Presence] in Urine
376
1867
2.85
46.99
5.2
3.0
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
447
2432
2.82
46.77
6.4
3.7
e6/l
81.0
109.2
0.28
386
1752
(3021879) Hepatitis B virus core Ab [Presence] in Serum
150
437
3.97
45.47
1.4
1.4
—
—
—
0
0
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
94
192
5.39
44.46
2.7
2.8
g/l
0.0
0.0
0.49
89
177
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
64
89
7.71
44.20
1.4
1.2
u/ml
2.4
6.6
1.01
30
41
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
29
10
30.01
43.38
1.2
1.1
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
97
215
4.98
41.72
2.7
2.7
g/l
37.1
37.4
0.20
92
185
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
229
918
3.06
41.67
3.4
2.4
%
20.5
22.4
1.17
205
786
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
213
820
3.15
41.57
1.6
1.6
—
—
—
0
0
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
198
734
3.23
41.16
4.4
4.0
u/l
243.0
256.2
0.44
191
689
(46235355) HIV 1 and 2 tests - Meaningful Use set
240
997
2.98
40.89
1.9
1.8
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
223
892
3.05
40.62
7.4
5.1
mmol/l
1.1
1.0
1.15
212
813
(3022948) Iron [Moles/volume] in Serum or Plasma
249
1066
2.91
40.04
3.2
2.3
umol/l
11.3
12.8
2.82
236
987
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
86
179
5.24
39.73
2.6
1.5
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
488
2934
2.61
39.44
7.9
4.7
g/l
33.6
35.4
9.38
468
2723
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
251
1096
2.85
38.74
1.3
1.3
iu/ml
33.3
34.1
0.05
75
344
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
36
27
13.89
38.44
1.1
1.1
ratio
1.0
1.1
—
19
9
(3004789) Transferrin [Mass/volume] in Serum or Plasma
231
980
2.88
37.48
3.3
2.3
g/l
2.3
2.3
1.19
217
908
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
171
622
3.20
36.34
2.6
2.3
g/l
0.2
0.2
0.47
161
579
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
50
67
7.88
35.56
1.5
1.1
u/ml
—
—
—
0
0
(3020779) Urea [Moles/volume] in Serum or Plasma
161
572
3.25
35.54
7.9
6.9
mmol/l
11.4
10.0
1.43
153
540
(3037756) Immunofixation for Serum or Plasma
77
161
5.17
35.32
1.3
1.7
—
—
—
0
0
(4306422)
52
76
7.23
34.28
1.3
1.2
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
679
5008
2.96
33.14
8.5
4.0
mm/h
18.7
12.6
13.87
652
4602
(3030905) Polymorphonuclear cells [#/volume] in Blood
64
120
5.70
33.07
4.8
3.3
e9/l
4.8
4.3
0.85
64
120
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
82
193
4.60
32.63
1.4
1.3
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
64
123
5.55
32.19
5.1
3.5
%
61.7
57.7
1.58
64
123
(3017817) Protein [Mass] in Urine collected for unspecified duration
46
63
7.67
32.08
1.8
2.4
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
23
10
23.63
31.56
1.1
1.0
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
234
1097
2.58
30.41
3.8
3.2
mmol/l
0.8
0.8
4.28
220
1032
(3018418) pH of Serum or Plasma
357
2028
2.33
30.26
6.5
3.8
ph
7.4
7.4
1.08
107
376
(40761536) Microorganisms panel - Urine sediment
150
561
3.04
30.02
7.2
3.7
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
61
121
5.36
29.62
1.3
1.2
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
505
3338
2.31
29.58
6.1
3.6
estimate
0.0
0.0
0.00
179
623
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
314
1704
2.36
29.43
3.1
2.2
mg/l
3.4
3.1
1.24
281
1435
(40758558) Short blood count panel - Blood
312
1694
2.35
29.15
10.7
6.7
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
478
3109
2.27
28.81
8.2
5.9
mmol/l
1.2
1.2
0.77
433
2796
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
93
265
3.83
28.61
1.7
2.1
u/l
39.0
39.1
0.01
74
235
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
508
3398
2.28
28.46
9.2
6.6
mmol/l
1.2
1.2
1.00
402
2868
(3032080) INR in Blood by Coagulation assay
442
2794
2.24
28.45
17.0
9.7
inr
1.3
1.3
0.20
189
802
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
49
83
6.21
28.06
1.2
1.1
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
503
3377
2.24
27.56
6.1
3.7
estimate
0.0
0.0
0.50
177
601
(3012501) Base excess in Blood by calculation
64
141
4.83
27.53
6.3
4.4
mmol/l
3.1
2.7
0.40
50
89
(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay
47
78
6.33
27.45
1.2
1.1
%
132.8
118.2
1.04
47
72
(3021601) Nitrite [Presence] in Urine by Test strip
498
3337
2.23
27.32
7.6
5.0
estimate
0.0
0.0
0.50
187
625
(4268621)
41
60
7.14
26.94
2.6
2.3
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
519
3548
2.24
26.92
8.3
6.1
umol/l
11.0
11.5
0.56
503
3357
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
434
2771
2.19
26.66
3.0
2.2
nmol/l
77.7
77.1
0.16
403
2449
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
681
5243
2.66
26.59
13.5
7.3
u/l
82.3
78.5
1.58
660
4891
(1616796) Gas panel - Central venous blood
62
137
4.81
26.57
6.1
3.6
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
115
395
3.22
26.47
1.6
1.2
u/ml
282.5
265.1
0.06
109
358
(3026493) Urate [Moles/volume] in Serum or Plasma
308
1719
2.26
26.44
3.8
2.6
umol/l
4543.9
8750.4
0.92
278
1476
(3001122) Ferritin [Mass/volume] in Serum or Plasma
442
2867
2.16
25.78
3.9
2.7
ug/l
176.0
133.2
1.15
410
2620
(3029937) Albumin [Presence] in Urine by Test strip
316
1798
2.22
25.73
7.1
3.9
estimate
0.0
0.0
0.69
180
600
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
68
171
4.24
24.77
2.0
2.9
%
220.3
196.7
1.06
63
165
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
226
1137
2.36
24.50
2.4
1.8
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
129
495
2.90
24.40
2.4
1.5
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
30
34
9.12
24.30
1.2
1.2
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
625
4710
2.32
24.17
7.4
4.3
—
—
—
0
0
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
78
221
3.79
24.12
3.4
3.8
mg/l
35.0
47.6
0.43
62
180
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
77
217
3.81
23.99
3.4
3.7
ratio
2.5
1.9
—
10
22
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
68
176
4.12
23.83
4.0
4.0
mg/l
1.8
1.6
0.65
63
158
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
88
273
3.49
23.77
2.8
1.8
ug/l
2.5
3.0
0.11
80
237
(3007164) IgA [Mass/volume] in Serum or Plasma
242
1270
2.28
23.66
1.9
1.5
g/l
3.3
2.5
3.71
190
752
(3034860) Kappa light chains.free [Mass/volume] in Serum
77
220
3.76
23.51
3.5
3.8
mg/l
56.5
87.3
0.51
61
178
(3036489) Thrombin time
77
223
3.70
23.05
2.1
2.3
s
21.4
21.3
0.09
66
201
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
135
549
2.74
22.82
5.4
3.6
mmol/l
1.2
1.2
0.73
123
475
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
28
7
41.36
22.78
1.3
1.3
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
337
2052
2.08
22.30
2.7
2.1
u/l
143.3
245.5
1.85
313
1930
(40767503) Oxygen content in Capillary blood by calculation
57
136
4.43
22.20
4.5
2.1
%
15.8
15.5
0.13
30
67
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
91
301
3.27
22.18
1.5
2.0
g/l
1.5
1.5
0.20
77
264
(3012516) Albumin [Mass/volume] in Urine
331
2015
2.07
21.81
4.2
3.1
mg/l
483.1
313.5
0.25
231
1253
(3041096) Erythrocytes [Presence] in Urine by Automated
306
1813
2.09
21.66
5.2
3.3
—
—
—
0
0
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
64
171
3.97
21.46
1.8
2.2
mg/l
11.4
12.4
0.35
57
157
(3024980) IgG subclass 4 [Mass/volume] in Serum
45
92
5.11
21.08
1.8
1.7
g/l
0.8
0.8
0.09
28
71
(3013826) Glucose [Moles/volume] in Serum or Plasma
547
4022
2.06
20.88
6.4
4.7
mmol/l
6.9
6.7
1.28
526
3766
(3020682) Albumin/Creatinine [Ratio] in Urine
341
2129
2.02
20.69
5.6
3.8
mg/mmol
17.0
9.0
1.55
248
1326
(3009508) Creatinine [Moles/volume] in Urine
341
2147
2.00
20.04
4.4
3.0
mmol/l
6.9
7.6
2.38
295
1784
(3031040) Bacteria [#/volume] in Urine by Automated count
593
4523
2.09
20.04
7.0
4.5
e6/l
10.2
3403.2
—
6
73
(3024139) IgG subclass 3 [Mass/volume] in Serum
33
54
6.32
19.51
1.4
1.2
g/l
0.3
0.5
0.66
19
36
(3028192) IgG subclass 2 [Mass/volume] in Serum
33
54
6.32
19.51
1.4
1.2
g/l
2.8
2.8
0.00
19
36
(3027135) IgG subclass 1 [Mass/volume] in Serum
33
54
6.32
19.51
1.4
1.2
g/l
5.7
7.2
1.45
19
37
(3026008) Bacteria identified in Urine by Culture
340
2155
1.98
19.47
4.3
3.2
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
67
198
3.59
19.43
1.6
1.6
iu/ml
0.2
0.1
0.49
22
44
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
331
2083
1.98
19.31
4.1
3.1
ng/l
1859.0
1409.1
1.16
297
1769
(3004616) Nuclear Ab [Presence] in Serum
36
66
5.66
18.98
1.5
1.3
—
—
—
0
0
(4062490)
33
56
6.10
18.82
1.4
1.2
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
70
220
3.38
18.47
4.2
2.7
u/ml
0.3
0.4
1.20
44
122
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
26
35
7.64
18.32
2.3
1.7
%
12.4
11.9
—
10
18
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
31
52
6.15
17.88
1.3
1.2
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
31
52
6.15
17.88
1.3
1.2
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
31
52
6.15
17.88
1.3
1.2
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
31
53
6.04
17.55
1.3
1.2
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
31
53
6.04
17.55
1.3
1.2
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
31
53
6.04
17.55
1.3
1.2
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
159
789
2.26
17.21
2.2
1.8
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
57
164
3.66
17.19
3.6
4.0
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
159
791
2.25
17.10
2.2
1.8
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
30
51
6.07
17.08
2.9
1.7
e9/l
1.2
1.0
0.25
21
24
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
24
32
7.69
17.04
2.6
1.8
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
380
2589
1.86
16.78
6.6
3.8
—
—
—
0
0
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
70
235
3.16
16.58
2.0
2.0
ug/l
256.2
435.9
0.44
60
220
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
191
1049
2.07
15.85
1.4
1.3
u/ml
7.6
12.1
0.66
65
386
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
198
1103
2.04
15.80
4.1
2.9
e6/l
3.7
2.5
0.79
127
602
(3002032) Base excess in Venous blood by calculation
136
659
2.27
15.49
5.8
3.8
mmol/l
1.7
2.1
0.53
116
523
(3021960) Folate [Moles/volume] in Serum or Plasma
268
1669
1.89
15.40
1.9
1.5
nmol/l
19.9
20.9
0.46
233
1396
(3016650) Hepatitis A virus Ab [Presence] in Serum
42
105
4.16
15.40
1.1
1.1
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
244
1485
1.91
14.98
1.9
1.7
mg/l
1.2
1.2
0.13
204
1127
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
319
2124
1.82
14.65
3.3
2.5
u/l
52.5
57.2
1.94
291
1958
(3015377) Calcium [Moles/volume] in Serum or Plasma
344
2352
1.79
14.39
4.0
3.4
mmol/l
2.3
2.4
0.58
308
2037
(40768446) Kidney Pathology biopsy report
17
18
9.62
14.37
1.4
1.3
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
92
388
2.54
14.23
1.8
1.5
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
370
2600
1.76
13.97
2.2
2.1
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
34
78
4.50
13.91
1.3
1.7
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
200
1169
1.94
13.70
3.9
2.7
e6/l
0.9
1.2
0.90
127
662
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
50
156
3.35
13.34
1.6
1.5
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
263
1692
1.81
13.27
6.0
3.8
%
86.4
89.6
0.99
256
1649
(21494814) CD8 cells/100 lymphocytes in Specimen
15
15
10.17
13.16
2.5
1.5
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
26
50
5.34
13.03
1.3
1.7
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
114
550
2.24
13.03
5.7
3.6
ng/l
102.0
83.4
1.23
103
478
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
41
115
3.70
12.84
2.9
2.6
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
43
125
3.57
12.78
4.8
2.6
—
—
—
0
0
(3014576) Chloride [Moles/volume] in Serum or Plasma
156
856
2.01
12.75
7.1
6.6
mmol/l
104.0
104.2
0.24
150
832
(3019309) Folate [Moles/volume] in Red Blood Cells
217
1336
1.85
12.53
2.0
1.7
nmol/l
1323.2
1174.5
1.44
175
1000
(3000991) Gas panel - Venous blood
117
585
2.16
12.22
7.3
8.1
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
36
96
3.87
12.12
1.4
1.6
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
63
238
2.78
12.11
2.7
3.0
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
13
12
10.99
11.98
2.8
1.6
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
49
162
3.15
11.91
1.3
1.7
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
36
98
3.79
11.78
1.1
1.1
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
39
113
3.57
11.66
1.4
1.4
u/ml
112.1
111.8
0.01
13
15
(3052851) Hemolysis interference index of Serum or Plasma
55
198
2.90
11.55
3.4
3.0
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
147
817
1.97
11.51
1.7
1.4
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
313
2186
1.69
11.49
3.7
3.2
u/l
36.7
32.8
0.62
283
2082
(3000093) Morphology [Interpretation] in Blood Narrative
27
61
4.54
11.26
1.1
1.1
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
41
126
3.37
11.22
1.3
1.2
u/ml
272.0
245.2
0.19
22
71
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
40
121
3.42
11.21
1.5
1.7
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
79
347
2.41
11.18
6.1
4.3
mmol/l
23.7
24.4
1.30
73
318
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
53
193
2.87
10.91
1.4
1.1
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
40
124
3.34
10.80
1.4
1.4
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
138
768
1.96
10.72
3.0
2.4
ug/g
124.5
133.1
0.16
108
601
(3042111) Morphology [Interpretation] in Bone marrow Narrative
38
115
3.41
10.65
1.5
1.5
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
46
157
3.04
10.61
1.4
1.6
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
41
131
3.24
10.56
1.2
1.2
—
—
—
0
0
(3004809) Band form neutrophils/100 leukocytes in Blood
36
107
3.47
10.38
4.0
3.4
%
1.2
1.3
0.07
29
86
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
45
154
3.03
10.34
1.5
1.6
—
—
—
0
0
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
27
66
4.19
10.22
1.3
1.2
u/l
46.1
52.5
0.41
22
50
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
12
13
9.35
9.89
1.2
1.1
—
—
—
0
0
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
20
39
5.23
9.87
1.9
1.6
u/l
7.2
9.8
0.18
13
21
(3003396) Base excess in Arterial blood by calculation
140
805
1.89
9.82
6.0
7.6
mmol/l
1.3
1.3
0.03
105
626
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
92
456
2.14
9.78
5.7
3.7
kpa
5.3
5.2
0.37
87
424
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
88
429
2.18
9.75
5.7
3.7
mmol/l
2.3
2.0
0.34
70
320
(3009343) pH of Capillary blood
91
451
2.14
9.67
5.6
3.7
ph
7.4
7.4
0.22
26
48
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
20
40
5.10
9.61
2.5
1.7
e6/l
459.0
500.0
0.14
15
32
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
41
139
3.05
9.58
1.5
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
41
139
3.05
9.58
1.5
1.3
—
—
—
0
0
(3020891) Body temperature
63
270
2.44
9.41
4.5
4.5
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
34
104
3.37
9.39
1.5
1.3
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
12
14
8.68
9.36
1.7
1.6
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
134
773
1.87
9.28
3.1
2.7
umol/l
9.1
8.2
0.21
114
661
(3022145) Colonoscopy Study observation
130
746
1.88
9.15
1.4
1.3
—
—
—
0
0
(3019060) Gas panel - Arterial blood
92
469
2.08
9.08
5.0
5.4
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
26
68
3.91
9.01
1.2
1.2
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
111
608
1.95
8.98
2.5
2.3
u/l
47.4
33.9
0.65
100
513
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
137
806
1.84
8.90
6.1
7.6
kpa
5.0
5.1
0.30
127
770
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
13
18
7.32
8.86
1.1
1.1
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
220
1488
1.65
8.69
1.9
1.7
pmol/l
431.8
25989138.4
1.42
182
1239
(3042631) Mycobacterium sp identified in Specimen
31
94
3.39
8.69
3.2
2.3
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
641
5560
1.67
8.67
38.6
17.7
%
14.3
13.7
15.19
634
5441
(3037121) Protein [Mass/volume] in Urine
59
255
2.41
8.66
4.1
3.3
g/l
0.2
0.2
0.10
31
107
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
354
2684
1.56
8.63
5.9
3.7
ng/l
50.0
49.9
0.00
272
1897
(3027801) Oxygen [Partial pressure] in Arterial blood
136
807
1.82
8.58
6.1
7.6
kpa
11.7
12.0
0.39
127
771
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
402
3149
1.54
8.38
5.3
4.0
—
—
—
0
0
(3023183) Ammonium ion [Moles/volume] in Plasma
42
156
2.78
8.37
3.6
3.1
umol/l
33.7
34.2
0.05
32
128
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
30
93
3.31
8.14
1.3
1.5
—
—
—
0
0
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
35
121
2.98
7.94
1.2
1.2
u/l
89.4
41.1
0.47
26
107
(3048929) Epstein Barr virus Ab [Presence] in Serum
49
203
2.50
7.89
1.4
1.2
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
599
5159
1.58
7.82
4.4
3.8
pmol/l
15.1
14.9
1.86
536
4635
(3006184) Hemoglobin [Mass/volume] in Capillary blood
40
151
2.73
7.75
4.4
2.0
g/l
125.3
125.5
0.02
35
111
(3022217) INR in Platelet poor plasma by Coagulation assay
144
897
1.73
7.66
29.4
25.3
inr
1.5
1.3
0.45
21
115
(40768797) Stomach Pathology biopsy report
146
915
1.72
7.60
1.4
1.2
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
741
6761
1.90
7.58
35.6
14.2
mg/l
21.6
24.3
2.06
681
5334
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
364
2834
1.51
7.55
2.3
2.0
pmol/l
91.7
94.6
0.53
211
1450
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
522
4381
1.52
7.50
4.3
3.1
u/l
68.6
49.0
4.14
482
4076
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
191
1289
1.63
7.49
4.8
4.0
ng/l
277.6
316.4
0.10
154
1024
(3013293) Extractable nuclear Ab [Presence] in Serum
12
9
13.51
7.40
1.4
2.0
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
221
1550
1.58
7.37
6.2
3.6
—
—
—
0
0
(4035726)
100
570
1.86
7.15
1.5
1.4
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
34
124
2.82
7.04
2.3
1.6
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
23
66
3.56
7.03
1.3
2.5
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
36
136
2.72
6.98
1.7
1.6
—
—
—
0
0
(3016502) Oxygen saturation in Arterial blood
119
721
1.76
6.95
6.6
8.0
%
96.2
95.4
1.25
114
692
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
32
114
2.88
6.91
1.3
1.5
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
93
524
1.87
6.89
4.8
2.6
ml/min/173m2
58.0
66.5
1.37
55
216
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
29
98
3.03
6.87
1.3
1.5
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
27
88
3.14
6.79
1.3
1.5
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
193
1334
1.58
6.79
3.4
3.1
mmol/l
2.5
2.5
3.91
172
1169
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
25
78
3.27
6.74
2.7
1.6
%
52.2
60.9
0.39
13
59
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
15
32
4.76
6.71
1.5
1.6
—
—
—
0
0
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
18
45
4.07
6.65
2.7
1.9
e6/l
881.4
825.1
—
7
19
(3044640) Blood type and Crossmatch panel - Blood
283
2136
1.49
6.62
3.3
2.4
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
12
21
5.78
6.60
4.2
3.8
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
24
74
3.31
6.60
1.4
1.6
—
—
—
0
0
(3007566) Smooth muscle Ab [Titer] in Serum
41
171
2.47
6.54
1.4
1.2
titre
218.6
72.0
—
7
15
(40761535) Cells panel - Urine sediment
96
557
1.82
6.48
6.5
3.1
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
15
33
4.61
6.48
1.5
1.6
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
204
1442
1.55
6.47
1.3
1.2
u/ml
1.8
1.9
0.05
69
377
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
71
373
1.99
6.47
5.3
9.0
mmol/l
24.4
24.7
0.29
65
347
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
21
61
3.51
6.32
1.2
1.3
—
—
—
0
0
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
13
26
5.06
6.24
2.4
1.7
ug/l
125.4
54.4
0.54
13
26
(21494434) Karyotype in Bone marrow
21
62
3.45
6.17
1.1
1.1
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
14
31
4.58
6.00
1.0
1.3
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
28
102
2.81
5.84
1.1
1.1
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
42
187
2.31
5.83
1.9
1.4
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
98
591
1.75
5.81
3.9
3.1
ng/l
258.3
223.6
0.35
89
547
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
16
41
3.96
5.73
1.4
1.5
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
40
177
2.32
5.64
1.3
1.2
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
10
17
5.94
5.63
1.1
1.1
—
—
—
0
0
(3002256) Pathology report gross observation
129
848
1.62
5.53
1.3
1.3
—
—
—
0
0
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
8
5
16.14
5.42
1.0
1.0
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
156
1078
1.55
5.40
1.5
1.5
—
—
—
0
0
(3016750) Collection duration of Urine
16
43
3.77
5.39
1.4
2.3
min
516.9
495.1
0.22
11
29
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
15
39
3.90
5.28
3.3
4.3
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
12
26
4.67
5.27
1.1
1.0
—
—
—
0
0
(3004775) Volume in Urine collected for unspecified duration
18
54
3.39
5.19
1.4
2.4
ml
738.8
629.6
0.29
12
34
(3026389) Candida sp identified in Specimen by Organism specific culture
22
76
2.95
5.06
1.3
1.3
—
—
—
0
0
(40768441) Liver Pathology biopsy report
18
55
3.32
5.05
1.2
1.3
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
681
6261
1.49
4.60
7.2
5.8
mmol/mol
41.4
40.0
2.91
636
5756
(3044889) 12 lead EKG panel
542
4788
1.38
4.59
5.2
3.8
—
—
—
0
0
(44806071)
9
11
8.26
4.57
1.0
1.1
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
27
111
2.48
4.50
1.4
1.5
—
—
—
0
0
(3004451) EKG impression Narrative
14
39
3.63
4.50
1.4
1.2
—
—
—
0
0
(3000012) Reticulocyte production index
15
45
3.38
4.34
1.9
1.5
—
—
—
0
0
(3034426) Prothrombin time (PT)
10
22
4.59
4.31
1.3
1.4
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
35
167
2.14
4.19
3.8
3.3
nmol/l
0.8
0.9
0.26
25
130
(3043409) Potassium [Moles/volume] in Arterial blood
41
208
2.02
4.18
4.1
3.7
mmol/l
3.9
3.9
0.14
34
192
(3013512) EKG study
257
2041
1.38
4.18
4.9
4.0
—
—
—
0
0
(3027273) Bicarbonate [Moles/volume] in Venous blood
58
331
1.81
4.18
5.4
3.1
mmol/l
25.2
25.1
0.08
58
326
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
9
13
6.98
4.17
1.0
1.2
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
672
6199
1.44
4.11
5.4
4.7
mu/l
2.0
1.9
0.45
615
5603
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
16
52
3.12
4.10
2.8
1.3
%
22.6
25.6
—
7
36
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
12
32
3.79
4.09
1.8
2.5
u/ml
954.2
713.0
0.39
12
32
(4027681)
12
32
3.79
4.09
1.2
1.2
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
69
418
1.71
4.06
2.5
1.6
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
36
176
2.09
4.06
2.2
2.4
ug/min
116.2
46.1
0.66
20
104
(40768806) Pleura Pathology biopsy report
20
75
2.71
4.01
1.5
1.6
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
11
28
3.97
3.98
2.0
2.7
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
12
33
3.68
3.93
1.3
1.1
—
—
—
0
0
(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma
13
38
3.46
3.91
1.3
1.2
u/l
5.3
8.2
0.78
13
32
(3003434) Protein [Mass/volume] in Pleural fluid
23
95
2.46
3.83
1.4
1.5
g/l
34.7
30.4
0.55
16
82
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
14
44
3.22
3.79
1.1
1.2
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
14
44
3.22
3.79
1.1
1.2
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
18
66
2.77
3.77
2.6
1.6
—
—
—
0
0
(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum
6
5
12.07
3.77
1.3
1.0
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
19
72
2.68
3.75
1.5
1.4
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
685
6373
1.43
3.71
30.6
13.2
ml/min/173m2
77.7
79.5
1.08
631
5216
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
10
25
4.04
3.70
1.0
1.1
—
—
—
0
0
(3008152) Bicarbonate [Moles/volume] in Arterial blood
70
437
1.66
3.70
9.3
7.6
mmol/l
24.5
24.5
0.04
65
407
(3051611) Lipemic interference index of Serum or Plasma
18
67
2.72
3.67
1.8
2.9
—
—
—
0
0
(44813793)
14
45
3.15
3.66
1.1
1.1
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
34
171
2.03
3.59
1.8
1.7
e6/l
10726.8
17167.7
0.63
26
124
(3024928) Oxygen saturation in Venous blood
32
158
2.07
3.54
3.2
3.8
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
457
4024
1.30
3.46
3.1
2.9
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
25
114
2.23
3.38
2.2
1.3
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
12
37
3.28
3.35
1.3
1.6
—
—
—
0
0
(3017354) Segmented neutrophils/100 leukocytes in Blood
17
65
2.65
3.32
6.0
2.8
%
51.3
58.8
0.52
11
44
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
9
19
4.78
3.24
1.0
1.2
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
9
19
4.78
3.24
1.2
1.2
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
30
150
2.04
3.24
1.3
1.4
u/l
13.1
9.1
0.72
22
116
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
31
157
2.01
3.23
1.2
1.1
—
—
—
0
0
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
7
11
6.41
3.19
1.4
1.5
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
19
80
2.41
3.08
1.1
1.1
—
—
—
0
0
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
6
8
7.54
3.06
1.3
1.4
—
—
—
0
0
(3036048) Francisella tularensis Ab [Titer] in Serum
6
8
7.54
3.06
1.3
1.1
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
13
46
2.86
2.93
1.0
1.1
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
21
95
2.24
2.92
3.3
2.6
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
10
30
3.36
2.91
1.1
1.1
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
736
7004
1.45
2.91
35.9
16.6
mmol/l
139.1
139.7
6.17
722
6815
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
16
64
2.53
2.88
1.1
1.1
—
—
—
0
0
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
7
13
5.42
2.87
1.1
1.3
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
22
103
2.17
2.83
1.1
1.1
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
203
1641
1.31
2.80
3.1
2.3
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
8
18
4.48
2.80
1.0
1.0
—
—
—
0
0
(3023199) Leukocytes [#/volume] in Pleural fluid
19
84
2.29
2.79
1.4
1.4
e6/l
1670.3
1489.0
0.09
12
59
(3037692) Legionella sp identified in Specimen by Organism specific culture
10
31
3.25
2.78
1.3
1.2
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
10
31
3.25
2.78
1.1
1.1
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
12
42
2.88
2.76
2.0
3.0
—
—
—
0
0
(3022313) Gas panel - Capillary blood
54
342
1.62
2.75
6.1
3.8
—
—
—
0
0
(3043870) Heparin induced platelet Ab [Units/volume] in Serum
5
6
8.37
2.75
1.2
1.2
—
—
—
0
0
(3016330) Potassium [Moles/time] in 24 hour Urine
5
6
8.37
2.75
1.0
1.2
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
752
7202
1.47
2.69
20.5
10.2
u/l
26.5
26.0
0.39
732
6929
(3023103) Potassium [Moles/volume] in Serum or Plasma
736
7022
1.43
2.68
36.2
16.7
mmol/l
4.0
4.0
0.21
719
6820
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
8
19
4.24
2.68
3.4
1.6
—
—
—
0
0
(3028308) Erythrocytes [#/volume] in Pleural fluid
17
74
2.32
2.59
1.5
1.3
e6/l
11472.3
49349.6
—
8
43
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
11
38
2.92
2.59
1.0
1.0
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
17
354
0.47
2.56
1.4
1.4
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
14
56
2.53
2.54
1.1
1.9
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
56
366
1.57
2.53
1.6
1.3
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
16
69
2.34
2.49
1.1
1.1
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
30
166
1.84
2.48
1.4
1.3
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
23
116
2.01
2.47
1.1
1.6
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
15
63
2.41
2.47
1.1
1.2
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
8
21
3.84
2.46
2.4
2.1
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
28
152
1.87
2.45
1.6
2.0
u/l
3104.5
2639.2
—
8
58
(3008757) Leukocyte morphology finding [Identifier] in Blood
18
83
2.19
2.42
4.9
3.7
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
8
22
3.66
2.37
1.0
1.0
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
8
22
3.66
2.37
1.3
1.1
ug/l
11.9
8.7
—
8
22
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
81
582
1.43
2.34
2.7
2.5
ug/l
5.4
7.3
0.96
68
506
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
102
766
1.38
2.30
2.0
1.8
%
1.8
1.5
2.71
86
672
(40761539) Cells [Type] in Urine sediment by Light microscopy
6
13
4.64
2.27
1.0
1.1
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
15
66
2.30
2.25
1.7
1.3
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
32
524
0.60
2.22
1.5
1.7
—
—
—
0
0
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
5
9
5.58
2.21
11.6
10.2
mmol/l
4.2
7.1
—
5
9
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
52
346
1.54
2.20
2.3
2.4
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
14
61
2.32
2.15
2.2
2.4
—
—
—
0
0
(40757373) Influenza virus identified in Isolate
6
14
4.31
2.15
1.2
1.4
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
9
30
3.02
2.15
1.0
1.2
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
33
198
1.69
2.11
1.4
1.5
ug/g
274.3
298.3
0.28
21
124
(3013727) Leukocytes other/100 leukocytes in Blood
8
25
3.22
2.10
3.1
5.2
%
48.7
49.2
—
8
25
(3003327) Ova and parasites identified in Stool by Light microscopy
34
207
1.67
2.07
1.6
1.6
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
46
303
1.55
2.05
2.3
1.8
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
43
280
1.56
2.02
2.7
1.8
—
—
—
0
0
(3003338) MCHC [Mass/volume]
529
5659
0.82
2.00
40.7
18.7
g/l
328.4
332.2
14.31
524
5614
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
15
70
2.16
1.99
1.0
1.3
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
13
57
2.30
1.98
1.2
1.2
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
16
77
2.10
1.97
1.3
1.2
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
7
21
3.35
1.97
1.1
1.0
—
—
—
0
0
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
17
84
2.05
1.96
1.5
1.2
nmol/l
0.5
0.6
0.99
17
79
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
12
51
2.37
1.95
2.3
1.1
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
29
173
1.70
1.92
1.3
1.3
miu/ml
213.0
227.1
—
7
81
(3047189) Immunofixation for 24 hour Urine
9
34
2.66
1.87
1.2
1.8
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
26
152
1.73
1.85
1.6
1.3
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
10
40
2.52
1.84
2.3
3.2
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
6
17
3.55
1.84
3.3
1.5
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
5
12
4.19
1.82
1.0
1.0
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
53
371
1.46
1.80
9.7
10.5
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
7
23
3.06
1.80
1.0
1.0
miu/ml
1302.3
1523.5
—
7
23
(3010144) Erythrocytes [#/volume] in Synovial fluid
13
60
2.19
1.78
1.8
1.4
e6/l
9311.7
73508.5
—
6
40
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
65
872
0.72
1.74
5.3
4.5
%
31.9
32.3
0.12
47
570
(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma
5
13
3.86
1.71
2.0
1.7
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
5
13
3.86
1.71
4.8
6.0
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
39
259
1.53
1.71
2.5
1.7
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
6
19
3.17
1.66
1.8
2.9
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
6
19
3.17
1.66
2.8
2.0
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
8
31
2.60
1.66
1.0
1.0
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
8
31
2.60
1.66
1.0
1.0
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
16
83
1.95
1.65
1.1
1.0
—
—
—
0
0
(3042585) Pyridoxine [Moles/volume] in Serum or Plasma
7
25
2.81
1.65
1.6
1.3
nmol/l
73.7
97.0
—
7
17
(3036603) Volume of Urine
11
49
2.26
1.64
1.5
1.6
—
1975.6
—
0
11
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
11
49
2.26
1.64
1.2
1.2
—
—
—
0
0
(3024471) HLA-A [Type]
5
14
3.59
1.61
1.0
1.0
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
10
43
2.34
1.60
1.0
1.3
—
—
—
0
0
(3017704) Immunofixation for Urine
10
43
2.34
1.60
1.1
1.6
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
15
77
1.97
1.60
1.5
1.2
nmol/l
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
62
458
1.38
1.59
1.8
1.7
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
6
20
3.01
1.58
1.2
1.2
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
7
26
2.71
1.58
1.3
1.9
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
56
408
1.40
1.56
1.2
1.2
iu/ml
135.8
139.2
0.02
26
168
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
12
57
2.12
1.55
1.7
1.5
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
12
57
2.12
1.55
1.7
1.5
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
12
57
2.12
1.55
1.7
1.5
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
8
33
2.44
1.54
1.0
1.1
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
55
401
1.40
1.53
1.3
1.2
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
17
93
1.85
1.52
1.1
1.1
—
—
—
0
0
(4015189)
6
21
2.87
1.50
1.0
2.5
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
5
128
0.39
1.50
1.6
1.6
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
11
52
2.13
1.45
1.0
1.1
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
9
40
2.26
1.40
1.7
1.2
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
9
40
2.26
1.40
1.3
1.2
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
9
40
2.26
1.40
1.7
1.2
—
—
—
0
0
(3035880) pH of Pleural fluid
10
46
2.19
1.40
1.6
1.4
—
—
—
0
0
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
22
134
1.66
1.40
1.1
1.5
e6/l
5.6
153.4
1.50
14
109
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
22
134
1.66
1.40
1.1
1.4
e6/l
7.8
33.2
0.51
13
104
(3014765) Yersinia sp identified in Stool by Organism specific culture
31
206
1.52
1.39
1.3
1.1
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
41
570
0.70
1.39
1.3
1.4
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
12
60
2.01
1.38
1.5
1.3
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
31
208
1.51
1.34
1.3
1.2
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
9
43
2.10
1.30
1.6
1.6
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
637
6105
1.19
1.30
29.5
15.7
%
38.4
39.7
2.51
408
4298
(3011648) Oxygen content in Venous blood
11
55
2.01
1.27
1.9
4.8
%
14.1
10.9
1.30
11
55
(44790048)
14
77
1.83
1.26
1.3
1.5
—
—
—
0
0
(44790047)
14
77
1.83
1.26
1.3
1.5
—
—
—
0
0
(44790049)
14
77
1.83
1.26
1.3
1.5
—
—
—
0
0
(44806118)
14
77
1.83
1.26
1.3
1.5
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
5
117
0.42
1.25
1.0
1.4
—
—
—
0
0
(4198724)
6
25
2.41
1.24
3.0
1.8
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
8
36
2.23
1.24
2.3
3.5
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
5
19
2.64
1.21
1.0
1.0
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
173
1506
1.19
1.21
7.1
3.9
kg/l
1.0
1.0
0.60
25
214
(1761482) Bacteria [#/volume] in Urine by Culture
28
189
1.50
1.20
4.0
4.5
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
32
223
1.45
1.18
1.5
1.6
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
13
222
0.58
1.15
1.2
1.7
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
0
35
0.00
1.15
0.0
6.7
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
48
624
0.76
1.10
2.9
2.0
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
725
7058
1.22
1.09
28.8
13.4
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
8
41
1.96
1.09
1.1
2.0
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
254
2302
1.15
1.06
3.0
2.8
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
32
229
1.41
1.05
1.6
1.3
iu/l
19.2
28.1
1.04
26
191
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
5
22
2.28
1.03
2.8
3.3
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
5
22
2.28
1.03
2.8
3.3
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
7
34
2.07
1.03
2.0
1.5
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
7
34
2.07
1.03
2.0
1.5
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
7
34
2.07
1.03
2.0
1.5
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
7
34
2.07
1.03
2.0
1.5
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
15
91
1.66
1.01
1.1
1.2
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
36
266
1.37
0.99
2.1
2.8
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
7
36
1.95
0.97
1.1
1.6
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
7
36
1.95
0.97
1.1
1.6
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
657
6370
1.15
0.90
4.2
3.9
mmol/l
1.4
1.3
3.66
592
5774
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
28
203
1.39
0.88
1.3
1.1
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
10
56
1.80
0.88
1.1
1.8
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
765
7513
1.23
0.87
46.9
21.0
e9/l
254.3
247.6
1.60
752
7312
(3024731) MCV [Entitic volume]
765
7514
1.23
0.86
46.8
20.9
fl
92.0
91.1
4.76
757
7391
(3035941) MCH [Entitic mass]
765
7515
1.23
0.85
46.7
20.9
pg
30.2
30.3
0.41
757
7390
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
12
72
1.68
0.85
1.7
1.6
—
—
—
0
0
(3026361) Erythrocytes [#/volume] in Blood
765
7516
1.23
0.84
46.9
21.0
e12/l
4.3
4.5
12.78
751
7291
(3000492) Spirometry study
76
636
1.21
0.84
1.7
1.5
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
6
31
1.94
0.84
1.8
1.1
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
6
31
1.94
0.84
1.8
1.1
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
765
7517
1.23
0.84
47.0
21.0
e9/l
7.6
6.7
15.77
752
7289
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
45
565
0.78
0.83
2.8
1.9
—
—
—
0
0
(3000963) Hemoglobin [Mass/volume] in Blood
765
7519
1.22
0.82
47.3
21.1
g/l
129.6
135.0
18.56
757
7390
(3004716) Salmonella sp identified in Stool by Organism specific culture
43
339
1.28
0.80
1.3
1.3
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
10
58
1.73
0.80
1.0
1.0
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
20
139
1.45
0.80
1.5
1.3
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
16
106
1.52
0.79
1.3
1.1
u/ml
0.5
2.7
—
9
45
(3037556) Urate [Mass/volume] in Serum or Plasma
0
26
0.00
0.78
0.0
1.3
—
—
—
0
0
(3010726) Horse dander IgE Ab [Units/volume] in Serum
14
90
1.57
0.78
1.3
1.1
u/ml
—
4.1
—
0
19
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
10
59
1.70
0.76
1.1
1.3
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
14
91
1.55
0.75
1.0
1.2
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
24
175
1.38
0.75
2.2
1.6
—
—
—
0
0
(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal
9
54
1.67
0.74
1.3
1.1
nmol/l
1.3
1.6
—
9
46
(40768795) Lymph node Pathology biopsy report
9
55
1.64
0.73
1.2
1.1
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
9
55
1.64
0.73
1.4
1.9
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
15
100
1.51
0.73
5.4
2.8
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
5
25
2.01
0.72
2.4
1.6
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
5
25
2.01
0.72
2.4
1.6
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
29
220
1.33
0.72
2.0
1.6
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
11
68
1.63
0.72
1.7
1.7
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
5
26
1.93
0.70
2.4
1.6
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
29
221
1.32
0.70
2.0
1.6
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
9
58
1.56
0.70
2.8
2.2
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
86
744
1.17
0.69
3.9
4.2
ug/l
92.3
30.6
0.51
70
619
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
13
85
1.54
0.69
3.7
3.7
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
29
222
1.32
0.69
2.1
1.6
—
—
—
0
0
(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma
5
27
1.86
0.68
3.2
2.3
umol/l
64.4
47.3
—
5
19
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
46
375
1.24
0.68
2.2
3.2
pmol/l
4.1
4.5
2.32
39
337
(3011288) Drugs identified in Urine by Screen method
20
146
1.38
0.64
4.0
2.1
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
27
208
1.31
0.62
2.1
1.6
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
674
6592
1.12
0.62
5.1
4.6
mmol/l
6.0
6.0
0.22
614
5961
(3025577) Chromium [Mass/volume] in Blood
8
50
1.61
0.61
2.8
2.1
ug/l
2.5
2.2
—
8
41
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
680
6658
1.12
0.59
4.7
4.4
mmol/l
4.4
4.6
8.07
610
6124
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
10
64
1.57
0.58
1.1
1.1
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
6
36
1.67
0.56
1.2
1.2
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
692
6788
1.12
0.56
5.1
4.9
mmol/l
2.5
2.7
8.41
617
6210
(3027944) Amphetamines [Presence] in Urine
28
221
1.28
0.56
2.1
1.6
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
6
37
1.63
0.55
1.0
1.2
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
53
453
1.18
0.52
2.4
3.1
e9/l
5.2
3.9
2.54
39
343
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
674
6610
1.10
0.52
4.6
4.3
mmol/l
1.4
1.5
4.35
605
6037
(3003740) Influenza virus B Ag [Presence] in Specimen
13
92
1.42
0.50
1.0
1.1
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
22
172
1.29
0.48
1.0
1.2
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
13
93
1.40
0.48
1.0
1.1
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
62
707
0.87
0.48
1.5
1.6
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
15
111
1.36
0.47
1.5
1.5
—
—
—
0
0
(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma
7
49
1.43
0.46
1.6
1.9
nmol/l
18.3
22.3
—
7
44
(3023430) Cat dander IgE Ab [Units/volume] in Serum
10
69
1.45
0.44
1.3
1.1
u/ml
—
6.8
—
0
23
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
5
31
1.62
0.43
1.0
1.3
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
5
31
1.62
0.43
1.8
1.1
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
5
31
1.62
0.43
1.0
1.0
—
—
—
0
0
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
5
32
1.57
0.42
11.8
3.6
u/l
209.2
218.1
—
5
32
(3034274) Bile acid [Moles/volume] in Serum --fasting
8
57
1.41
0.42
2.0
2.0
umol/l
19.6
8.6
—
8
39
(3051593) INR in Capillary blood by Coagulation assay
5
33
1.52
0.41
1.0
14.4
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
14
105
1.34
0.41
2.1
1.8
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
42
362
1.17
0.40
3.9
3.6
—
—
—
0
0
(3024263) Appearance of Synovial fluid
5
35
1.43
0.39
1.8
1.5
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
10
71
1.41
0.39
1.7
1.7
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
25
302
0.82
0.39
1.8
1.9
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
12
89
1.35
0.38
2.3
1.2
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
12
89
1.35
0.38
2.3
1.2
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
12
89
1.35
0.38
2.2
1.2
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
12
90
1.34
0.36
2.3
1.2
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
9
122
0.73
0.35
2.3
1.8
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
6
44
1.37
0.34
8.2
2.5
—
—
—
0
0
(3022621) pH of Urine by Test strip
51
453
1.13
0.34
3.5
3.1
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
12
91
1.32
0.34
2.3
1.2
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
12
91
1.32
0.34
2.3
1.2
—
—
—
0
0
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
14
176
0.79
0.32
2.2
1.8
nmol/l
34.1
39.2
0.47
14
166
(1617658) Protocol used for examination of sentinel lymph nodes
7
55
1.28
0.30
1.0
1.1
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
15
183
0.82
0.27
1.5
1.5
—
—
—
0
0
(3051101) Glucose [Moles/volume] in Cord blood
0
10
0.00
0.21
0.0
6.5
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(4133840)
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
183
1767
1.05
0.19
1.5
1.4
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
6
52
1.15
0.19
1.7
1.4
—
—
—
0
0
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
36
328
1.10
0.18
2.3
2.8
u/ml
47.1
59.3
0.21
36
315
(36660697) Celiac disease serology panel - Serum
54
503
1.08
0.18
1.2
1.1
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
52
484
1.08
0.18
2.8
2.2
nmol/l
12.9
13.4
0.12
41
424
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
7
62
1.13
0.17
1.6
1.3
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
7
63
1.11
0.17
1.1
1.5
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
5
70
0.71
0.16
1.0
1.6
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
17
149
1.14
0.15
1.0
1.4
nmol/l
1.2
0.9
0.44
12
126
(3019225) pH of Specimen
72
684
1.06
0.15
5.4
3.9
—
—
—
0
0
(1002224) Polysomnography panel
24
264
0.91
0.14
1.1
1.1
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
18
161
1.12
0.13
2.6
2.2
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
95
916
1.04
0.12
1.5
1.4
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
218
2138
1.03
0.11
4.8
4.9
ug/l
2.4
2.9
0.43
193
1907
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
5
44
1.14
0.10
1.0
1.1
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
12
135
0.89
0.10
1.6
1.2
—
—
—
0
0
(4010399)
51
488
1.05
0.09
1.6
1.4
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
178
1812
0.98
0.08
1.7
1.6
mmol/l
1.4
1.4
0.31
135
1537
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
17
184
0.92
0.07
1.3
1.5
—
—
—
0
0
(4281824)
8
76
1.05
0.07
1.0
1.1
—
—
—
0
0
(4146454)
8
76
1.05
0.07
2.9
2.7
—
—
—
0
0
(4034850)
25
235
1.07
0.07
12.2
9.6
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
168
1708
0.98
0.07
4.0
4.2
%
21.8
21.2
0.17
74
807
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
9
86
1.05
0.07
1.6
1.6
—
—
—
0
0
(4094501)
18
167
1.08
0.07
1.0
1.1
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
8
93
0.86
0.06
1.5
1.3
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
17
182
0.93
0.05
1.4
1.4
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
58
565
1.03
0.05
1.4
1.4
—
—
—
0
0
(3008898) HLA-B27 [Presence]
22
231
0.95
0.04
1.0
1.1
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
31
299
1.04
0.04
1.7
1.6
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
123
1246
0.98
0.04
2.6
2.9
ug/l
0.6
0.8
1.04
86
805
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
23
237
0.97
0.01
1.8
1.9
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
30
305
0.98
0.00
1.0
1.0
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
86
865
0.99
0.00
13.6
6.7
—
—
—
0
0
(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3032743) Legionella sp IgG Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(21494567) Legionella sp IgM Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3016273) Islet cell 512 Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3051339) Copper [Moles/volume] in Blood
0
5
0.00
0.00
0.0
1.2
—
16.7
—
0
5
(40766799) MGMT gene methylation score in Tissue by Molecular genetics method
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40768793) Breast Pathology biopsy report
17
170
1.00
0.00
1.0
1.3
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
8
79
1.01
0.00
2.4
2.2
—
—
—
0
0
(3028717) Thiamine [Mass/volume] in Blood
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
0
5
0.00
0.00
0.0
1.8
—
0.6
—
0
5
(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3012984) Norclozapine [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
13.6
—
—
—
0
0
(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3011335) Digoxin [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.2
—
—
—
0
0
(40758358) Immune stain study
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3034092) Cytoplasmic Ig cells/100 cells in Blood
0
5
0.00
0.00
0.0
4.4
—
—
—
0
0
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint L12_VASCULITISNAS and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| L12_VASCULITISNAS | 2.781 [2.39, 3.24] | < 0.001 |
| Birth year | 0.995 [0.99, 1.0] | 0.216 |
During the follow-up period (1.1.1998 — 31.12.2019), 1063 out of 2856 females with L12_VASCULITISNAS died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| L12_VASCULITISNAS | 2.679 [2.22, 3.24] | < 0.001 |
| Birth year | 0.99 [0.98, 1.0] | 0.032 |
During the follow-up period (1.1.1998 — 31.12.2019), 699 out of 1962 males with L12_VASCULITISNAS died.
Mortality risk
Mortality risk for people of age
years, who have L12_VASCULITISNAS.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.272% | 0.627% |
| 5 | 1.768% | 3.441% |
| 10 | 4.143% | 8.225% |
| 15 | 8.192% | 15.612% |
| 20 | 13.626% | 25.911% |
Relationships between endpoints
↥Index endpoint: L12_VASCULITISNAS – Other and unspecified vasculitis limited to skin
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data